Classer les publications sur l'année

  • Économie de la santé

    Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era

    CACOUB P, VAUTIER M, DESBOIS AC, LAFUMA A, SAADOUN D

    2017 - Liver International ;

  • Santé Publique et Epidémiologie

    Fuel poverty in France: Adapting an English Methodology to assess the health cost implications

    EZRATTY V, ORMANDY D, LAURENT MH, DUBURCQ A, LENCHI C, BOUTIERE F, CABANES PA, LAMBROZO J

    2017 - Indoor and Built Environment ;

  • Santé Publique et Epidémiologie

    Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases

    BAUJAT G, CHOQUET R, BOUEE S, JEANBAT V, COUROUVE C, RUEL A, MICHOT C, LE QUAN SANG KH, LAPIDUS D, MESSIAEN C, LANDAIS P, CORMIER-DAIRE V

    2017 - Orphanet Journal of Rare Diseases ;

  • Pharmaco-Epidémiologie

    Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study

    BERTIN P, FAGNANI F, DUBURCQ A, WORONOFF AS, CHAUVIN P, CUKIERMAN G, TROPÉ-CHIROL S, JOUBERT JM, KOBELT G

    2016 - Joint Bone Spine ; 83 - 1 : 47-52

  • Économie de la santé

    Cost-effectiveness model comparing dual-mobility to fixed-bearing designs for total hip replacement in France.

    EPINETTE JA, LAFUMA A, ROBERT J, DOZ M

    2016 - Orthop Traumatol Surg Res. ; 102 (2) : 143-8

  • Biométrie et Analyses de bases de données

    Déterminants des coûts du passage à l’insuline en France chez le patient diabétique de type 2: quelles pistes d’optimisation?

    HANAIRE H, ATTALI C, LECOINTRE B, FRAYSSE M, GOUET D, BABEL MR, CHARBONNEL B, SARKOZY F, GOURMELEN J, DETOURNAY B

    2016 - Santé Publique ; 28-6 : 781-789

  • Pharmaco-Epidémiologie

    An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.

    M LLIBRE J, RAFFI F, MOYLE G, BEHRENS G, BOUEE S, REILLY G, BORG P, PIONTKOWSKY D, ROGATTO F.

    2016 - PLoS One ; 11 (5) : e0155406

  • Pharmaco-Epidémiologie

    Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.

    BOUEE S, EMERY C, SAMSON A, GOURMELEN J, BAILLY C, COTTE FE.

    2016 - Thromb J. ; 14 (4) : doi: 10.1186

  • Pharmaco-Epidémiologie

    Prevalence of Gout in the Adult Population of France.

    BARDIN T, BOUEE S, CLERSON P, CHALES G, FLIPO RM, LIOTE F, PEREZ V, POIRAUD T, SCHAEVERBEKE T, RICHETTE P.

    2016 - Arthritis Care Res ; 68 (2) : 261-6

  • Pharmaco-Epidémiologie

    Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.

    FAGNANI F, PHAM T, CLAUDEPIERRE P, BERENBAUM F, DE CHALUS T, SAADOUN C, JOUBERT JM, FAUTREL B.

    2016 - J Med Econ ; 25 : 1-10

  • Santé Publique et Epidémiologie

    Bouge ta santé à Clichy-sous-Bois » : une approche intersectorielle de l’activité physique

    CZAPLICKI G, DONIO V, NOSSEREAU C, FIKOJEVIC M, RICHARD D

    2016 - Santé publique ; 28 (supp.1) : 175-8

  • Économie de la santé

    Low rate of intensification in type 2 diabetic patients inadequately controlled with basal insulin: the INTERDIA study

    ROUSSEL R, GOURDY P, GAUTIER JF, GUERCI B, RACCAH D, BEHAR M, ROBERT J,DETOURNAY B

    2016 - Diabetes Manag ; 6-6 : 119–127

  • Pharmaco-Epidémiologie

    Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France : relationships with age, aetiology and hormonal parameters

    GOICHOT B, CARON PH, LANDRON F, BOUEE S

    2016 - Clin Endocrinol ; 84 (3) : 445-51

  • Pharmaco-Epidémiologie

    Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

    RICHETTE P, CLERSON P, BOUÉE S, CHALÈS G, DOHERTY M, FLIPO RM, LAMBERT C, LIOTE F, POIRAUD T, SCHAEVERBEKE T, BARDIN T.

    2015 - Ann Rheum Dis ; 74 - 9 : 1684-1690

  • Pharmaco-Epidémiologie

    Impact of socioeconomic status on health and quality of care in adults with type 2 diabetes in France: the Entred 2007 study

    FOSSE-EDORH S, FAGOT-CAMPAGNA A, DETOURNAY B, BIHAN H, ESCHWEGE E, GAUTIER A, DRUET C

    2015 - Diabet Med ; 32 (11) : 1438-1444